Clinical Trials Logo
  1. Home
  2. Myoma;Uterus
  3. NCT03009812
  4. Details
NCT03009812 Clinical Trial

Transverse vs Longitudinal Incision in Myomectomy

Myoma;Uterus Clinical Trial

Official title:
Transverse Versus Longitudinal Uterine Incision in Abdominal Myomectomy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03009812
Other study ID # MY-789
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date January 23, 2018

Study information
Verified date April 2019
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Aim of the study is to compare between transverse and longitudinal uterine incision in abdominal myomectomy regarding intraoperative blood loss.

Recruitment information / eligibility
Status Completed
Enrollment 52
Est. completion date January 23, 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

1. Inclusion criteria for myomectomy as; abnormal uterine, pressure related symptoms, infertility and recurrent pregnancy loss in patients between 18 and 45 years old

2. Single myoma.

3. Women with BMI between 18.5-29.9 kg/m2.

Exclusion Criteria:

1. Pregnancy.

2. Patients with bleeding tendency

3. Previous laparotomies.

4. Patients with concomitant pelvic pathologies, such as ovarian cysts.

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Longitudinal uterine incision

• Transverse uterine incision

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Ain Shams University

Outcome
Type Measure Description Time frame Safety issue
Primary Intraoperative blood loss 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Active, not recruiting NCT06114758 - Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
Not yet recruiting NCT05967936 - Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy N/A
Not yet recruiting NCT05932082 - The Impact of Myomectomy on IVF Outcomes N/A
Recruiting NCT04748978 - OPPIuM Technique and Myolysis With Diode Laser Dwls N/A
Recruiting NCT05271981 - Fertility After Uterine Artery Embolization
Completed NCT05025410 - Remimazolam and Remifentanil Without Neuromuscular Blocking Agent
Recruiting NCT03483142 - the Effect of Misoprostol on Intra-operative Blood Loss During Myomectomy Operation Phase 3
Completed NCT03533907 - Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
Completed NCT05811286 - The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study N/A
Not yet recruiting NCT03570879 - Laparoscopic Myomectomy With Morcellation or Transvaginal Extraction of Surgical Specimens.
Not yet recruiting NCT04364581 - Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions Phase 4
Recruiting NCT06067971 - Evaluation of the Feasibility of Using Augmented Reality in Laparoscopic Surgery, by a Clinical Study During Gynecological Laparoscopic Surgical Procedures. (ENDORA2) N/A
Recruiting NCT04990076 - Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
Recruiting NCT06325501 - Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy Phase 3
Completed NCT05761418 - Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy Phase 3
Recruiting NCT04311073 - Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies Phase 3
Active, not recruiting NCT05930769 - Retrospective Study on the Evaluation of the Impact of Augmented Reality Usage in Gynecological Laparoscopy on Patients Operated Between 2017 and 2021 (ImpactRA)
Recruiting NCT03550703 - Open Label Immunotherapy of Myoma Phase 2
Completed NCT04482959 - Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy Phase 4